Skin specialists say there are red flags to watch for that warn of undiagnosed diabetes or pre-diabetes or that current ...

Scientists Discover New Receptor for Nerve Growth Factor--a Promising Target for Treating Pain Dec. 5, 2024 — Researchers have found a new receptor for nerve growth factor that plays an ...

Mighty Mike' has a date with teenage sensation Luke Littler who is aiming to be come the youngest darts player ever to lift ...

For people suffering from chronic knee pain, especially those over 50, a new treatment is offering hope and relief.

Diabetic Foot Disease is defined as a syndrome in which peripheral neuropathy and peripheral vascular disease may result in foot ...

Physical therapy can be effective in treating a condition more than 3 million Americans live with every day: chronic pain.

CFTX-1554 is under clinical development by Eli Lilly and Co and currently in Phase I for Peripheral Neuropathic Pain.

ANP-390 is under clinical development by AlphaNavi Pharma and currently in Phase I for Peripheral Neuropathic Pain.

Autonomix Medical shares were up 24% to $4.10 after the company said it received a patent from the U.S. Patent and Trademark Office.

Core offers FDA-approved nVNS devices with growth potential in healthcare and military markets. Click here to find out what ...

Discover the truth about the Nooro Foot Massager, a portable EMS device designed to relieve foot pain, improve circulation, ...

Introduction Neuromodulation devices are cutting-edge therapeutic tools that modulate nerve activity by delivering precise electrical im ...